Sulaquin, Gina F.

HRN: 21-53-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2022
CEFTRIAXONE 1G (VIAL)
07/10/2022
07/16/2022
IV DRIP
95mg
Q12
T/c Pertussis, Cannot Totally Rule Out Cardiac Pathology
Waiting Final Action 
07/10/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
07/10/2022
07/14/2022
VIA OGT
0.5mg
OD
T/c Pertussis, Cannot Totally Rule Out Cardiac Pathology
Waiting Final Action 
07/16/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/16/2022
07/22/2022
IVT
100mg
Q6 X 7 Days
Sepsis
Waiting Final Action 
07/16/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/16/2022
07/22/2022
19MG
Ivt
Q8 For 7 Days
Pertussis, Sepsis
Waiting Final Action 
07/17/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
07/17/2022
07/23/2022
IVT
10mg
OD
Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: